Cannabis 13Fs: Tilray, Canopy, Curaleaf, Trulieve Decoder

US-listed and OTC-traded cannabis equities form a distinctive regulated-emerging-industry corner of institutional 13F positioning. Tilray Brands, Canopy Growth (CGC), Aurora Cannabis (ACB), Curaleaf Holdings (CURLF OTC), and Trulieve Cannabis (TCNNF OTC) anchor the cohort. Multi-year federal legalization uncertainty, state-level cannabis program dynamics, banking access constraints, and Section 280E tax burden drive distinctive institutional patterns. Reading cannabis 13F positioning requires understanding the federal-regulatory framework plus the multi-year state-program cycle dynamics.

The cannabis business model

Cannabis faces four primary economic drivers:

1. Federal legalization uncertainty. Cannabis remains Schedule I under US federal law. Multi-year DEA rescheduling proceeding plus SAFE Banking legislation drive long-cycle regulatory framework changes.
2. State-level program dynamics. 24+ states plus DC have adult-use cannabis programs; 38+ states have medical programs. Multi-year state program expansion plus selective new state legalization drive operator revenue trajectory.
3. Banking access constraints. Cannabis companies face limited banking access due to federal Schedule I status. Multi-year SAFE Banking legislation pursuit aims to enable broader banking relationships.
4. Section 280E tax burden. US Section 280E denies cannabis operators tax deductions for ordinary business expenses creating effective 40-70%+ tax rates. Multi-year DEA rescheduling could eliminate 280E.

Major cannabis 13F-tracked names

Tilray Brands (TLRY)

Canadian licensed producer plus US craft beer plus emerging US cannabis assets. NASDAQ-listed provides broader institutional access than US plant-touching operators.

Canopy Growth (CGC)

Canadian licensed producer. Multi-year operational restructuring plus US plant-touching strategy (Canopy USA).

Aurora Cannabis (ACB)

Canadian licensed producer. Multi-year operational restructuring plus medical cannabis focus.

Curaleaf Holdings (CURLF OTC)

Largest US multi-state operator (MSO). Operations across 17+ states. NYSE-listing pending federal rescheduling.

Trulieve Cannabis (TCNNF OTC)

Multi-state operator with Florida dominance. NYSE-listing similarly contingent on federal status.

How institutional managers position around cannabis

Three patterns:

Pattern 1: NASDAQ-listed Canadian concentration

TLRY-concentrated active manager positions reflect broader institutional access through NASDAQ listing.

Pattern 2: Federal-rescheduling positioning

US MSO positions during DEA rescheduling proceeding reflect 280E elimination thesis plus potential NYSE/NASDAQ uplisting.

Pattern 3: ESG-mandate exclusionMany institutional ESG-mandated portfolios exclude cannabis. Reading positions across mandate frameworks reveals exclusion boundaries.

How to read cannabis 13F positioning

Three rules:

Rule 1: Identify federal-regulatory exposure

NASDAQ-listed Canadian producers vs OTC-traded US MSOs face different institutional accessibility.

Rule 2: Watch DEA rescheduling milestones

DEA rescheduling proceeding plus SAFE Banking legislation drive multi-year regulatory framework visibility.

Rule 3: Cross-check state program data

State adult-use legalization plus program expansion data drives long-cycle revenue trajectory.

What cannabis positioning signals

1. NASDAQ-listed conviction. Concentrated TLRY positions signal NASDAQ-accessible cannabis thesis.
2. Federal-rescheduling conviction. Concentrated US MSO positions signal rescheduling thesis.
3. State-expansion conviction. Concentrated state-specific operator positions signal state program expansion thesis.

For real-time tracking of cannabis 13F activity, see the institutional signals feed.